News & Updates
Showing Paediatrics articles
Showing
Show Multimedia Only

Canagliflozin lowers HbA1c in children with T2D
16 Sep 2024
byStephen Padilla
Treatment with canagliflozin results in clinically meaningful reductions in glycated haemoglobin (HbA1c), when compared with placebo, in children and adolescents with type 2 diabetes (T2D), as shown by the results of a phase III study presented at EASD 2024.
16 Sep 2024

Tapinarof safe, efficacious for moderate-to-severe AD in children, adults
06 Sep 2024
byStephen Padilla
Treatment with tapinarof cream 1% once daily demonstrates significant efficacy with a favourable safety profile among adults and children with moderate-to-severe atopic dermatitis (AD), a study has shown.
06 Sep 2024






